MENU
+Compare
PAVS
Stock ticker: NASDAQ
AS OF
Dec 18, 04:54 PM (EDT)
Price
$1.40
Change
+$0.20 (+16.67%)
Capitalization
13.5M

PAVS Paranovus Entertainment Technology Ltd Forecast, Technical & Fundamental Analysis

a nutraceutical and dietary supplements producer, which engages in the development, manufacturing, and sales of a variety of products made from herbal and animal extracts.

PAVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PAVS with price predictions
Dec 17, 2024

PAVS in +21.74% Uptrend, advancing for three consecutive days on December 13, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PAVS advanced for three days, in of 180 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 12, 2024. You may want to consider a long position or call options on PAVS as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PAVS just turned positive on December 13, 2024. Looking at past instances where PAVS's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 63 cases where PAVS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PAVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PAVS broke above its upper Bollinger Band on December 13, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PAVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.264) is normal, around the industry mean (6.504). P/E Ratio (0.000) is within average values for comparable stocks, (26.887). PAVS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.471). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (0.148) is also within normal values, averaging (66.929).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PAVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
PAVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published Dividends

PAVS paid dividends on August 17, 2020

Paranovus Entertainment Technology Ltd PAVS Stock Dividends
А quarterly dividend of $0.01 per share was paid with a record date of August 17, 2020, and an ex-dividend date of August 07, 2020. Read more...
A.I. Advisor
published General Information

General Information

a nutraceutical and dietary supplements producer, which engages in the development, manufacturing, and sales of a variety of products made from herbal and animal extracts.

Industry FoodSpecialtyCandy

Profile
Fundamentals
Details
Industry
N/A
Address
Number 11, Dongjiao East Road
Phone
+86 5997828808
Employees
80
Web
https://www.happ.org.cn
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GOCAX11.72-0.06
-0.51%
Gabelli International Small Cap A
NSOIX17.44-0.11
-0.63%
North Star Opportunity I
UOPIX126.13-1.12
-0.88%
ProFunds UltraNASDAQ-100 Inv
DLBMX17.42-0.21
-1.19%
MassMutual Small Cap Opps A
ODIIX131.77-1.74
-1.30%
Invesco Discovery R6

PAVS and Stocks

Correlation & Price change

A.I.dvisor tells us that PAVS and PIFMY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVS and PIFMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVS
1D Price
Change %
PAVS100%
+9.19%
PIFMY - PAVS
24%
Poorly correlated
+5.60%
STKL - PAVS
22%
Poorly correlated
+1.42%
ACOPF - PAVS
22%
Poorly correlated
N/A
FRPT - PAVS
22%
Poorly correlated
-0.46%
TATYF - PAVS
20%
Poorly correlated
N/A
More